LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 152 filers reported holding LOXO ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $22,003,000 | -17.9% | 128,800 | -35.8% | 0.02% | +53.3% |
| Q2 2018 | $26,804,000 | +69.2% | 200,500 | +46.0% | 0.02% | -11.8% |
| Q1 2018 | $15,840,000 | -17.0% | 137,300 | -33.7% | 0.02% | -22.7% |
| Q3 2017 | $19,078,000 | +3122.6% | 207,100 | +895.7% | 0.02% | +2100.0% |
| Q4 2015 | $592,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,188,920 | $385,883,000 | 63.39% |
| DAFNA Capital Management LLC | 262,121 | $24,147,000 | 14.99% |
| Casdin Capital, LLC | 360,000 | $33,163,000 | 9.36% |
| Opaleye Management Inc. | 130,000 | $11,975,000 | 4.24% |
| SECTORAL ASSET MANAGEMENT INC | 245,226 | $22,590,000 | 2.91% |
| BVF INC/IL | 238,386 | $21,960,000 | 2.79% |
| Crawford Lake Capital Management, LLC | 81,725 | $7,529,000 | 2.70% |
| AWM Investment Company, Inc. | 125,000 | $11,515,000 | 2.01% |
| Orbimed Advisors | 1,728,000 | $159,183,000 | 1.52% |
| Eventide Asset Management | 285,000 | $26,254,000 | 1.49% |